Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.86

+1.3%

Dec 24 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2812)	6/30/2010 12:20:19 PM
From: Jibacoa	1 Recommendation Read Replies (1) of 3722

RXII was up 8.51% and is still up 6.67% on volume about 1/4 its ADV The stock opened with a small UG that has not been yet closed.<g> bigcharts.marketwatch.com At the Jefferies 2010 Global Life Sciences Conference earlier this month, RXII commented on its new focused RNAi therapeutic strategy. It said that its therapeutic platform has the potential to be broadly applicable to multiple therapeutic areas.<g> I already mentioned some of RXII claims about its effective delivery of its sd-rxRNA to retinal cells in the mouse eye in my note in May.<g> The stock dropped below its support at the $4 level, which is now a resistance area.<g> bigcharts.marketwatch.com The ACTAY is $15 RXII was able to trim some its loss on the 1stQ and the ELs for 2010 & 2011 are around $0.85 & $0.75 vs. $1.24 in 2009 I would put a TT around $5 pending further developments, which wouldn't be a bad % gain from present levels.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next